Welcome to the Madin America podcast, your source for science, psychiatry, and social justice.

So today we have Dr. Machari Keshavan and Dr. Raquel Mashel-Mashel-Gaately.

Dr. Keshavon is a board-certified psychiatrist, the Stanley Kaup Professor of Psychiatry at Harvard Medical School,

and professor and academic head of psychiatry at Beth Israel Deacon's Medical Center.

His work focuses on neurobiological models of psychotic disorders and on the development

and implementation of early interventions

with biopsychosocial treatment strategies. He is also the editor-in-chief of schizophrenia

research. Dr. Raquel Mechlam Gately is an assistant professor of psychology and the Department

of Psychiatry at Harvard Medical School. She is also a licensed clinical psychologist and

neuropsychologist who directs the Consumer Advisory Board and Neuropsychology Research in the

Psychosis Research Program at the Massachusetts Mental Health Center, Public Psychiatry Division

of the Beth Israel Deaconis Medical Center. She has felt privilege to be partnering with

the Consumer Advisory Board

and participatory mental health research, including recent projects on therapeutic alliance

and quality of life in as well as renaming schizophrenia. We're going to be talking about

a particular project of Dr. Keshevan and Meshalam Gatley's on renaming schizophrenia.

But first, I'd like for us to learn more a bit about you, about the both of you.

Can you please tell us and tell the audience what drew you to your respective fields?

Yes. Thank you, Marilyn.

So as you mentioned, I'm a psychiatrist and I have practiced

this profession for over three decades. There were many moments that were kind of consciously

or unconsciously drawing me towards psychiatry from early on in my medical career, including the fact that,

...